ccm2 Antibody

What is CCM2 and what cellular functions does it serve?

CCM2 is a 49-52 kDa protein that functions as a component of the CCM signaling pathway, which regulates heart and vessel formation and integrity. It primarily stabilizes endothelial cell junctions and serves as a scaffold protein for MAP2K3-MAP3K3 signaling. Additionally, CCM2 plays a major role in modulating MAP3K3-dependent p38 activation induced by hyperosmotic shock . Mutations in CCM2, along with CCM1 and CCM3, are associated with cerebral cavernous malformations, highlighting its clinical significance in vascular pathology .

What types of CCM2 antibodies are available for research applications?

Multiple types of CCM2 antibodies are available for research, including mouse monoclonal antibodies (such as OTI2E4 clone) and rabbit polyclonal antibodies. These antibodies are generated using different immunogens - some target the full-length recombinant protein while others target specific peptide sequences . When selecting a CCM2 antibody, researchers should consider the specific experimental application, species reactivity requirements, and whether monoclonal specificity or polyclonal detection breadth is more important for the experimental design.

What are the typical applications for CCM2 antibodies in research?

CCM2 antibodies can be utilized in multiple experimental applications including:

These applications allow researchers to detect CCM2 expression, localization, and interaction partners in various experimental systems .

How should I design experiments to investigate CCM2-MEKK3 interactions?

The interaction between CCM2 and MEKK3 (MAP3K3) represents an important signaling node in vascular biology. To study this interaction:

• Co-immunoprecipitation assays: Transfect cells with tagged constructs (e.g., Flag-tagged CCM2 and HA-tagged MEKK3) and immunoprecipitate using anti-Flag antibodies. The lysate preparation should include buffer containing 20 mM Tris-HCl pH 7.4, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 0.5% NP-40, 1 mM DTT, and protease inhibitors .

• Domain mapping: Use truncated constructs to identify essential interaction domains. Evidence suggests the N-terminal region of MEKK3 and the harmonin homology domain (HHD) of CCM2 are critical for interaction .

• Competitive peptide assays: Design cell-permeable peptides based on the N-terminal portion of MEKK3 (residues 2-18) to disrupt the MEKK3-CCM2 interaction and assess functional consequences .

• Isothermal titration calorimetry (ITC): For direct binding analysis, purify CCM2 HHD and MEKK3 NPB1 domains and measure binding affinity through ITC, using purification protocols involving His-tag chromatography followed by size exclusion chromatography .

What controls should be included when validating CCM2 antibody specificity?

Proper validation of CCM2 antibody specificity requires multiple controls:

• Positive control samples: Use lysates from cells with confirmed CCM2 expression (e.g., MCF-7 cells) .

• Knockout/knockdown validation: Compare signal between wild-type samples and those with CCM2 depletion (CRISPR knockout or siRNA knockdown). Published research has utilized CCM2 knockdown in various experimental contexts .

• Peptide competition: Pre-incubate the antibody with excess immunizing peptide to confirm epitope-specific binding.

• Cross-reactivity assessment: Test for potential cross-reactivity with structurally similar proteins, particularly CCM2L, which shares sequence homology with CCM2 .

• Multiple antibody comparison: Compare results using antibodies targeting different epitopes of CCM2 to verify consistent detection patterns.

How can I optimize Western blot protocols for CCM2 detection?

For optimal Western blot detection of CCM2:

• Sample preparation: Lyse cells directly in SDS sample buffer or use a lysis buffer containing detergents like NP-40 (0.5%), protease inhibitors, and DTT .

• Running conditions: Use 10% SDS-PAGE gels for optimal resolution around the 49-52 kDa range where CCM2 migrates.

• Transfer optimization: For proteins in the 49-52 kDa range, semi-dry transfer at 15-20V for 30-45 minutes or wet transfer at 100V for 1 hour typically produces good results.

• Blocking conditions: Block membranes with 5% non-fat milk in TBST to minimize background.

• Antibody dilution: For most CCM2 antibodies, a 1:500-1:2000 dilution range is effective. Specifically, rabbit polyclonal antibody 26270-1-AP has been validated at these dilutions .

• Detection methods: ECL-based detection systems provide sufficient sensitivity for endogenous CCM2 detection .

What are the considerations for using CCM2 antibodies in immunohistochemistry?

Successfully employing CCM2 antibodies in immunohistochemistry requires attention to several technical details:

• Antigen retrieval: A critical step for CCM2 detection is proper antigen retrieval. The recommended method is using TE buffer at pH 9.0, though citrate buffer at pH 6.0 may also be effective as an alternative .

• Antibody dilution: Most antibodies work effectively at dilutions between 1:100-1:400, but optimization for specific tissues is recommended .

• Detection systems: Both DAB (3,3'-diaminobenzidine) and fluorescent secondary antibody detection systems can be employed.

• Tissue-specific considerations: CCM2 detection has been validated in human liver cancer tissue, but expression patterns vary across tissues due to differential vascular content.

• Controls: Include positive control tissues with known CCM2 expression and negative controls (either CCM2-negative tissues or primary antibody omission).

How should I purify recombinant CCM2 protein for biochemical studies?

Purification of recombinant CCM2 for structural and functional studies requires specific methodologies:

• Expression system: Transform expression plasmids (e.g., CCM2 HHD domain) into Rosetta (DE3) cells and induce expression with 0.5 mM IPTG when cultures reach A600=0.6 .

• Cell lysis: Resuspend cell pellets in buffer containing 500 mM NaCl, 20 mM Tris pH 8.5, DNaseI, DTT, and protease inhibitors. Lyse cells through freeze/thaw cycles in dry ice/ethanol bath followed by sonication .

• Purification steps:

  • Initial purification using nickel affinity chromatography (HisTrap columns)

  • Cleavage of His-tag using TEV protease

  • Further purification by ion exchange chromatography (Resource Q column)

  • Final polishing by size exclusion chromatography (S75 column)

• Buffer optimization: For ITC experiments and other binding studies, proteins should be dialyzed into 150 mM NaCl, 50 mM HEPES pH 7.5, and filtered through 0.1-μm filters .

What techniques are available to study CCM2-dependent signaling pathways?

To investigate CCM2-dependent signaling pathways:

• Phosphorylation analysis: Examine the phosphorylation status of downstream effectors such as MLC2 (myosin light chain 2), which can be modulated by disrupting the CCM2-MEKK3 interaction .

• Genetic interaction studies: Utilize morpholino knockdown approaches in model organisms such as zebrafish to examine genetic interactions between CCM2 and related genes like CCM1 (san/ccm1) and CCM2L .

• Knock-in mutations: Introduce specific mutations (e.g., CCM2 HHD A319D/A320D or MEKK3 NPB1 D13R) that disrupt protein-protein interactions to assess functional consequences .

• Pull-down assays: Use GST-fusion proteins of specific domains (e.g., GST-MEKK3 NPB1, GST-MEKK3 N, GST-MEKK3 PB1) to investigate domain-specific interactions with CCM2 .

How do I interpret discrepancies between calculated and observed molecular weights for CCM2?

The calculated molecular weight of CCM2 is 49 kDa, while the observed molecular weight in SDS-PAGE is approximately 52 kDa . This discrepancy is not uncommon in protein research and may be attributed to:

• Post-translational modifications: Phosphorylation, glycosylation, or other modifications can increase apparent molecular weight.

• Protein structure: Regions with high hydrophobicity or charged residues may affect migration in SDS-PAGE.

• Technical factors: Gel concentration, running conditions, and molecular weight marker calibration can influence apparent size.

To determine the cause of size discrepancy:

• Treat lysates with phosphatases or glycosidases to remove specific modifications

• Compare migration patterns under reducing and non-reducing conditions

• Utilize mass spectrometry to determine precise molecular mass

How should I approach troubleshooting non-specific banding patterns in CCM2 Western blots?

When encountering non-specific bands in Western blots using CCM2 antibodies:

• Antibody optimization: Titrate antibody concentrations to identify the optimal dilution that maximizes specific signal while minimizing background (typical range 1:500-1:2000) .

• Blocking optimization: Test different blocking agents (BSA vs. non-fat milk) and concentrations (3-5%).

• Validation with controls: Compare blots using CCM2 knockout/knockdown samples to identify which bands are specific.

• Cross-reactivity assessment: Consider whether non-specific bands may represent CCM2L or other structurally related proteins.

• Sample preparation: Optimize lysis conditions and include phosphatase inhibitors if studying phosphorylated forms.

• Develop with multiple antibodies: Use antibodies targeting different epitopes to confirm band specificity.

How can I quantitatively analyze CCM2-MEKK3 interaction data from co-immunoprecipitation experiments?

For quantitative analysis of co-immunoprecipitation data:

• Normalization approaches:

  • Normalize co-IP signal to input levels of both proteins

  • Compare the ratio of co-immunoprecipitated protein to immunoprecipitated protein

• Controls for interpretation:

  • Include negative controls (unrelated antibodies or IgG)

  • Use mutant constructs (e.g., MEKK3 with A6D/L7D mutations) as negative interaction controls

• Competition assays: Use increasing concentrations of competing peptides (e.g., MEKK3 N-peptide vs. mutant N-peptide) to demonstrate specificity and determine relative binding affinities .

• Quantification methods: Use densitometry software to measure band intensities, ensuring analysis remains in the linear detection range.

• Statistical analysis: Perform multiple independent experiments (n≥3) and apply appropriate statistical tests to determine significance of observed differences.